• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Infect Control Hosp Epidemiol. Author manuscript; available in PMC Jul 2, 2012.
Published in final edited form as:
PMCID: PMC3388111
NIHMSID: NIHMS384271

Modeling the Spread of Methicillin-Resistant Staphylococcus aureus (MRSA) Outbreaks throughout the Hospitals in Orange County, California

Abstract

Background

Since hospitals in a region often share patients, an outbreak of methicillin-resistant Staphylococcus aureus (MRSA) infection in one hospital could affect other hospitals.

Methods

Using extensive data collected from Orange County (OC), California, we developed a detailed agent-based model to represent patient movement among all OC hospitals. Experiments simulated MRSA outbreaks in various wards, institutions, and regions. Sensitivity analysis varied lengths of stay, intraward transmission coefficients (β), MRSA loss rate, probability of patient transfer or readmission, and time to readmission.

Results

Each simulated outbreak eventually affected all of the hospitals in the network, with effects depending on the outbreak size and location. Increasing MRSA prevalence at a single hospital (from 5% to 15%) resulted in a 2.9% average increase in relative prevalence at all other hospitals (ranging from no effect to 46.4%). Single-hospital intensive care unit outbreaks (modeled increase from 5% to 15%) caused a 1.4% average relative increase in all other OC hospitals (ranging from no effect to 12.7%).

Conclusion

MRSA outbreaks may rarely be confined to a single hospital but instead may affect all of the hospitals in a region. This suggests that prevention and control strategies and policies should account for the interconnectedness of health care facilities.

To date, most studies of methicillin-resistant Staphylococcus aureus (MRSA), which represents a continuing public health and health care system problem, have focused on individual or, at most, small groups of hospitals.1-10 Since a majority of MRSA-colonized individuals are asymptomatic and colonization can persist for substantial durations,11 endemic or epidemic changes in MRSA levels in one hospital could potentially affect MRSA levels in other hospitals. Numerous prior studies have reported MRSA outbreaks in health care settings and have often described intra- and interward transmission.3-9 Reports have occasionally included transmission between affiliated health care facilities,1,2,10 but regional evaluations are lacking. We sought to model the impact that a MRSA outbreak in one hospital has on all of the other hospitals in a single large metropolitan county where substantial interfacility patient sharing has been demonstrated previously.12,13

Methods

We constructed an agent-based model (ABM) to represent patient flow throughout all adult acute care hospitals in Orange County (OC), California, which together serve a population of 3.1 million people. The model included detailed representations of each hospital and allowed us to explore the effects of different sized hospital-level and ward-level outbreaks at various locations.

Population Data Sources

We incorporated hospital-specific data from several sources. First, detailed data on annual adult admissions and hospital length of stay (LOS) distributions came from 2006 patient-level hospitalization data from all OC hospitals.14 Second, prior published work provided detailed matrices on how OC hospitals share patients as both direct interfacility transfers and discharges and readmissions following an intervening stay at home or another location.12 Third, we obtained previously collected information about the number, size, volume, and average patient LOS within hospital intensive care units (ICUs) from prior county-wide healthcare facility surveys.15

Model Structure

Our ABM represented adult inpatients in all 29 acute care adult inpatient facilities. Each computer agent represented a virtual person (ie, a patient) who had a MRSA infection status of either positive or negative and who was moving among the general community and hospitals each simulated day.

Figure 1 depicts our model’s general structure. Each hospital consisted of general wards and ICUs (if applicable). To standardize our model, each ICU had 12 beds, each long-term acute care (LTAC) ward had 10 beds, and each general ward had 20 beds. For example, if a hospital had a total of 100 beds including 20 ICU beds, the simulated hospital consisted of 2 10-bed ICUs and 4 20-bed general wards. Upon admission, a patient had a probability of entering either an ICU or a general ward. The patient stayed in that ward for a certain LOS, which was drawn from a ward-specific probability distribution (Table 1). After the assigned LOS lapsed, a patient in a general ward was either discharged back into the community or transferred to another hospital on the basis of probabilities derived from our patient flow data.12 After each assigned ICU LOS lapsed, ICU patients transferred to a general ward for the remainder of their assigned hospital stay. Discharged patients had a probability of being readmitted or staying in the community that was based on hospital-specific data regarding patient readmission to any OC hospital within 1 year of discharge. Patients who tested positive for MRSA had a relative 30% increase in the probability of readmission to a hospital, which is consistent with previous findings.16 Time to readmission (ie, direct transfer or readmission after an intervening stay at home or elsewhere) also drew from hospital-specific data. Whether a readmitted patient went to the same or a different hospital was based on our detailed interfacility patient-sharing data matrices.12

Figure 1
Schematic flow of patients within the network and transmission.
TABLE 1
Model Inputs and Hospital Parameters

Transmission Model

MRSA transmission occurred within each hospital’s general wards and ICUs, where patients mixed homogeneously. Other than the transfer of ICU patients to general wards, no mixing occurred between wards. The following equation determined the number of patients who had test results that were positive for MRSA for the first time in each ward each day: number of new MRSA-positive test results in ward = βSI + (number of patients with MRSA that enter ward) – (number of patients with MRSA that leave ward). Specifically, defining I(t) as the number of infectious patients (ie, MRSA colonized or infected) in the ward at the start of day t, S(t) as the number of susceptible patients (ie, noncarriers of MRSA) in the ward at the start of day t, β as the transmission coefficient (which is parameterized for each hospital to generate a 1% incidence in the general wards, a 2% incidence in LTAC wards, and a 3% incidence in ICUs; Table 1), C(t) as the number of MRSA-positive patients entering the ward at the end of day t, and G(t) as the number of MRSA-positive patients leaving the ward at the end of day t, the equation is I(t + 1) − I(t) = β(S(t)I(t)) + C(t) − G(t), representing uniform mixing of susceptible and infective patients over the course of day t, plus net infective entrants at the end of day t.

Our initial baseline scenario assumed that patients who had positive test results for MRSA retained carriage indefinitely. Additional scenarios introduced MRSA carriage loss over time, with MRSA carriage duration drawn from a distribution based on published estimates.17-20 One-third of patients who had positive test results for MRSA had indefinite carriage,21 and the remaining experienced a linear carriage loss (6-month half-life). The model tracked MRSA prevalence (ie, number of MRSA-positive patients over total number of patients in that ward) in each hospital each day.

Experimental Scenarios

Experiments systematically implemented the following scenarios to each OC hospital (unless stated otherwise) and assessed the impact on all other OC hospitals: a sustained single-hospital MRSA outbreak increased the MRSA prevalence (among admitted patients) indefinitely (from 5% to 15%) in 1 hospital at a time; a temporary single-hospital MRSA outbreak increased the MRSA prevalence for 3 months (from 5% to 15%) in 1 hospital at a time; a single-hospital MRSA major outbreak increased the MRSA prevalence substantially (from 5% to 50%) in 1 hospital at a time; a regional MRSA outbreak increased the MRSA prevalence in all hospitals in and around the City of Orange (5 hospitals) from 5% to 15%; and a single-hospital ICU MRSA outbreak increased the MRSA prevalence (from 5% to 15%) in all ICUs in a single hospital. This scenario was systematically performed for each hospital. Each experiment was run in the model until it reached equilibrium (4-year run-in time) before an outbreak was introduced. Sensitivity analyses explored the effects of varying patient LOS (1 day vs a hospital-specific LOS distribution) and duration of MRSA colonization (range, indefinite to 1 day).

Analyses included an assessment of changes in MRSA prevalence in each hospital over time following each outbreak, that is, a relative increase in MRSA prevalence from preoutbreak levels. We explored whether the impact of an outbreak was associated with the following:13 hospital size (patient capacity), hospital in-degree (the total number of different hospitals that send patients to the given hospital), and hospital out-degree (the total number of different hospitals that receive patients from a given hospital).

Results

Outbreaks in different OC hospitals had varying effects on all other OC hospitals. The impact depended on the outbreak size and duration and the hospital size and connectedness (shared patients). In general, varying hospital LOSs and times to patient readmission had relatively little effect on the resulting prevalence changes.

Sustained Single-Hospital Outbreak

Figure 2 shows what happened to other hospitals over time after a single hospital experienced a MRSA outbreak (ie, an increase in prevalence from 5% to 15%). Following the outbreak, most other hospitals experienced an increase in prevalence and ultimately reached a new steady-state prevalence. For all but 3 hospitals, most of this increase occurred during the first 6 months following the outbreak, and it slowed considerably from 6 months to 1 year.

Figure 2
Effects of outbreak on other hospitals over time.

Figure 3 utilizes bubble maps to summarize the results of our experiments. Each column represents a single experiment. The number above each column indicates the hospital experiencing the outbreak. Each row in the column lists the relative change in prevalence from preoutbreak levels for all other OC hospitals. Overall, an outbreak that affected 15% of patients in one hospital led to a median increase in MRSA prevalence of 1.8% in all other OC hospitals. Increases were nonuniform across OC, with effects on other hospitals ranging from no effect to a 46.4% relative increase in MRSA prevalence when any other hospital experienced an outbreak. LTACs tended to experience the greatest relative percent change in prevalence: they were the most affected facility in 20 of the 29 outbreaks, with relative increases ranging from 0.5% to 46.4% (median, 3.1%). Conversely, LTAC outbreaks had relatively little effect on other OC hospitals (range, 0.9%–1.2%). Outbreaks in hospital 10 (the third largest in terms of bed capacity) resulted in the largest change throughout the network, with a median relative increase of 3.3% (range, 1.3%–46.4%). Among acute care facilities only, relative increases in prevalence of MRSA ranged from no effect to 14.2% (median, 1.5%).

Figure 3
Bubble maps for hospital-specific lengths of stay, with increased probability of transfer and delayed readmission, for a 15% increase in prevalence of methicillin-resistant Staphylococcus aureus (MRSA). Each column represents a single experiment. The ...

Figure 4A shows that an outbreak’s impact (median change in all other OC hospitals) correlated positively with the relevant hospital’s bed capacity (correlation coefficient [r] = 0.71). Of the 12 single-hospital outbreaks that caused a median change of at least 2.0% across the network, 7 occurred in hospitals that had capacities of at least 200 patients. Only 2 hospitals that had capacities of at least 200 caused relative changes in network prevalence of less than 2.0%. On the other hand, as Figure 4B demonstrates, smaller hospitals tended to be more affected by outbreaks in other hospitals (r = −0.51); only 1 hospital with a capacity of at least 150 patients experienced a relative change of at least 2.0% when any other hospital had an outbreak. LTACs, which have smaller capacities, tended to be the most affected.

Figure 4
Scatterplots of effects of (A) outbreaks on the network, (B) outbreaks on hospitals, (C) out-degree on the network (the total number of hospitals to which a given hospital sends patients), and (D) in-degree on hospitals (the total number of hospitals ...

It took years to achieve new steady-state values across OC hospitals following a single-hospital outbreak (Figure 3; mean, 2,511 days), and only 13% of hospitals reached new steady states within 6 months (17% did so within 1 year). Nevertheless, most hospitals experienced 70% of outbreak effects within 6 months (22% of hospitals) or 1 year (62% of hospitals). There was no difference in time to steady state between LTACs and acute care hospitals.

Figure 4C, 4D reveals that the outbreak impact correlated somewhat with the hospital’s degree. The higher the out-degree (ie, the total number of hospitals to which a given hospital sends patients) of the outbreak hospital, the greater the impact to the MRSA prevalence at other hospitals (Figure 4C). The greater the number of hospitals to which a given outbreak hospital sends patients, the larger the impact on the other hospitals (r = 0.78). In-degree (ie, the total number of hospitals from which a given hospital receives patients) correlated slightly with the relative change (r = 0.45) that a hospital experiences when there is an outbreak in any other OC hospital (Figure 4D); receiving patients from more hospitals resulted in a larger change in prevalence.

Adding MRSA carriage loss attenuated outbreak effects. An increase in prevalence from 5% to 15% effected a median change of 1.0% (range, no effect to 62.5%) on the network. MRSA loss resulted in a 44% decrease in the relative change in MRSA prevalence for the entire network (median relative change, 1.0% vs 1.8%).

Temporary Single-Hospital Outbreak

Figure 5 shows how MRSA prevalence changed following a 3-month outbreak in 2 example hospitals (16 and 17). The impact manifested and peaked within 6 months of the outbreak start but did not persist, as the prevalence of MRSA colonization returned to near-preoutbreak levels in about 1 year.

Figure 5
Effects of a 3-month outbreak on other Orange County hospitals.

Single-Hospital Major Outbreak

Figure 6 summarizes the results of a more dramatic single-hospital outbreak (an increase in MRSA prevalence from 5% to 50%) leading to a 5.6% median relative change throughout the network (range, 0.6%–212.0%). LTACs experienced the most change from outbreaks that occurred elsewhere but had the least impact on the network when experiencing outbreaks themselves. While time to steady state often took years to achieve (an average of 1,885 days, with 7% of hospitals reaching a new steady state in 6 months), most hospitals experienced 70% of outbreak effects within 1 year (52% of hospitals). There was no difference between LTACs and acute care hospitals in time to steady state.

Figure 6
Bubble maps for hospital-specific lengths of stay, with increased probability of transfer and delayed readmission, for a 50% increase in prevalence of methicillin-resistant Staphylococcus aureus (MRSA). Each column represents a single experiment. The ...

Regional MRSA Outbreak

A concerted outbreak (an increase in MRSA prevalence from 5% to 15%) affecting all 5 hospitals located in the City of Orange resulted in a median 7.3% relative increase (range, 3.0%–58.3%) throughout the rest of OC. A major outbreak (an increase in MRSA prevalence from 5% to 50%) led to a median 30.5% relative increase (range, 11.1%–258.6%). Again, LTACs manifested among the highest relative percent changes. The impact did not appear to correlate with physical distance from the City of Orange.

Single-Hospital ICU MRSA Outbreak

Even an outbreak in a single hospital’s ICUs affected hospitals throughout OC, causing a median 1.10% relative change in all other OC hospitals (range, no effect to 12.7%). LTACs experienced the greatest relative change in prevalence in 89% of ICU outbreaks.

Discussion

Our study emphasizes the substantial interconnectivity via patient sharing that exists among OC hospitals and that even a MRSA outbreak modeled in a single hospital’s ICUs eventually percolated throughout OC. Moreover, the connections are rather heterogeneous: a MRSA outbreak may not necessarily spread proximally but instead could spread by leaps and bounds. The effects depend on outbreak size and location and may not fully manifest immediately, often taking 6 months to 1 year. In general, outbreaks in larger and more connected hospitals have more wide-ranging effects, although this correlation is not perfect. Changing hospital LOSs did not appreciably change our results.

These findings have multiple implications. First, every MRSA outbreak, regardless of location (ie, even in a single ICU), is not simply the concern of a single hospital but is potentially a regional concern. In other words, hospitals are not “islands” but rather parts of a complex system. It may be important for all hospitals to be aware of any outbreak that occurs in their given region. Sharing infection control information can help other hospitals to prepare for potential dissemination of an outbreak. Hospitals may enhance the monitoring of patients transferred from a hospital experiencing an outbreak. Hospitals experiencing an outbreak may want to limit patient transfers or decolonize patients before discharge.

Second, a perceived MRSA outbreak in one hospital may be the result of practices or situations in another. While a hospital’s infection control specialists may be searching for the source of an outbreak in their hospital, the culprit could actually be miles away. Therefore, hospitals may benefit from sharing not only epidemiological information but also infection control policy and practice information to help coordinate efforts.

Third, hospitals should understand their connections with other hospitals and realize the implications of establishing or severing connections. In other words, while fiscal or service reasons may drive patient sharing, hospitals may want to anticipate and prepare for the infection control implications of changes in patient sharing. Knowing patient movement patterns (eg, via information systems) could benefit hospitals and infection control strategies and practices. Furthermore, hospitals may want to consider potential infection control implications when forming relationships with other facilities.

Fourth, since the impact of an outbreak can be far reaching and take time to manifest, patience and perseverance may be important for those tracking, preparing for, or responding to an outbreak. For example, if a connected hospital experiences a large outbreak, public health officials and hospital administrators may want to maintain heightened infection surveillance and control measures for an extended period of time.

Fifth, changing LOSs did not appear to substantially impact our MRSA results. This is a useful finding, as there has been considerable debate over the implications of shortening or lengthening LOSs.

Sixth, since the prevalence of MRSA in a community can affect the prevalence of MRSA in hospitals that admit patients from that community, increases of MRSA prevalence in a community can manifest as “outbreaks.” Therefore, hospitals may want to be aware of what is occurring in the community and nursing homes.

Finally, our findings emphasize systems thinking when considering MRSA and its control. Appropriate surveillance and interventions may require the coordination of various hospitals and efforts that span multiple organizations. Perhaps a central organization could coordinate infection control activities throughout a county.

Our study advances the existing literature by using more extensive real-world data and detailed representations of the structure of and transmission within each hospital. To our knowledge, it is the most extensive study of its kind in the United States. Some studies have examined networks of hospitals on a smaller scale, with theoretical representations of hospitals, or in other countries with different health systems.11,22-25

Although our model was based on extensive data from OC, the interconnectedness of hospitals in OC and our findings are likely not unique and could be applicable to other regions. A recent paper by Donker et al23 utilized referral data from the Dutch national medical register to model a hospital network in the Netherlands. While the US health care system differs from that of the Netherlands, our findings were similar. They also showed long times to achieve steady state for all hospitals in the network (up to 10 years) and that prevalence was related to the extent of a hospital’s referral patterns (ie, degree). Our study took further steps by building a more detailed hospital structure (including wards and ICUs) and transmission model, incorporating additional elements such as a MRSA loss rate, performing more sensitivity analyses, and showing the MRSA prevalence effects of an outbreak by hospital, outbreak size, and location. Also, our model included patient sharing that occurred beyond referrals (eg, patients choosing to use other hospitals). Future studies could explore other hospitals in the United States and other countries to confirm our findings.

Limitations

Models that include everything are not helpful. Hence, Einstein admonished that models be made as simple as possible, but no simpler. Accordingly, a number of factors were excluded, though they are suitable topics for future research. Our study focused on adults and did not include pediatric hospitals or long-term chronic care facilities (ie, nursing homes [not included in the Office of Statewide Health Planning and Development]) or their patients. However, a hospital outbreak could have originated in the transfer of a nursing home patient. Although a vast majority (86%) of patients stay within OC for hospital care, some do cross county lines. While the Office of Statewide Health Planning and Development database is quite comprehensive, no database can capture every single patient, especially those who are undocumented. Finally, it is unclear how generalizable our findings may be to other counties, although a large diversity of hospital types and sizes were represented.

Conclusion

Our results show that a MRSA outbreak, even in a single hospital’s ICU, can affect all the hospitals in a region. These effects may depend on outbreak size and location and often take time to fully manifest. Generally, outbreaks in larger and more connected hospitals affect a greater number of hospitals to a greater extent. Our results suggest that surveillance, prevention, and control strategies and policies should account for the interconnectedness of health care facilities. Future models may include representations of nursing homes.

Acknowledgments

We would like to thank Marc Lipsitch, PhD for his valuable guidance.

Financial support. This study was supported by the National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS) grants 1U54GM088491-0109 and 1U01 GM076672 and the Pennsylvania Department of Health. Computational resources were provided by the Center for Simulation and Modeling. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.

Footnotes

Potential conflicts of interest. All authors report no conflicts of interest relevant to this article.

references

1. McDonald JR, Carriker CM, Pien BC, et al. Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spread. Pediatr Infect Dis J. 2007;26(8):678–683. [PubMed]
2. Widerstrom M, Monsen T, Karlsson C, Wistrom J. Molecular epidemiology of methicillin-resistant coagulase-negative staphylococci in a Swedish county hospital: evidence of intra- and interhospital clonal spread. J Hosp Infect. 2006;64:177–183. [PubMed]
3. Sanchez-Garcia M, De la Torre MA, Morales G, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA. 2010;303(22):2260–2264. [PubMed]
4. Ludlam HA, Swayne RL, Kearns AM, et al. Evidence from a UK teaching hospital that MRSA is primarily transmitted by the hands of healthcare workers. J Hosp Infect. 2010;74(3):296–299. [PubMed]
5. van Rijen MM, Bosch T, Heck ME, Kluytman JA. Methicillin-resistant Staphylococcus aureus epidemiology and transmission in a Dutch hospital. J Hosp Infect. 2009;72(4):299–306. [PubMed]
6. Wang JT, Chang SC, Ko WJ, et al. A hospital-acquired outbreak of methicillin-resistant Staphylococcus aureus infection initiated by a surgeon carrier. J Hosp Infect. 2001;47(2):104–109. [PubMed]
7. Umoren I, Nakamatsu R, Sciortino C, et al. An investigation of an outbreak: methicillin resistant Staphylococcus aureus colonization in an intensive cardiac unit. J Ky Med Assoc. 2009;107(11):443–449. [PubMed]
8. Williams VR, Callery S, Vearncombe M, Simor AE. The role of colonization pressure in nosocomial transmission of methicillin-resistant Staphylococcus aureus. Am J Infect Control. 2009;37(2):106–110. [PubMed]
9. Monsen T, Karlsson C, Wistrom J. Spread of clones of multi-drug-resistant, coagulase-negative staphylococci within a university hospital. Infect Control Hosp Epidemiol. 2005;26(1):76–80. [PubMed]
10. Sader HS, Pignatari AC, Hollis RJ, Jones RN. Evaluation of interhospital spread of methicillin-resistant Staphylococcus aureus in Sao Paulo, Brazil, using pulsed-field gel electrophoresis of chromosomal DNA. Infect Control Hosp Epidemiol. 1994;15(5):320–323. [PubMed]
11. Robotham JV, Scarff CA, Jenkins DR, Medley GF. Methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and the community: model predictions based on the UK situation. J Hosp Infect. 2007;65(S2):93–99. [PubMed]
12. Huang SS, Avery TR, Song Y, et al. Quantifying inter-hospital patient sharing as a mechanism for infectious disease spread. Infect Control Hosp Epidemiol. 2010;31(11):1160–1169. [PMC free article] [PubMed]
13. Lee BY, McGlone SM, Song Y, et al. Social network analysis of patient sharing among hospitals in Orange County, California. Am J Publ Health. 2011;101(4):707–713. [PMC free article] [PubMed]
14. California Health and Human Services Agency . Office of Statewide Health Planning and Development. Sacramento, CA: http://www.oshpd.ca.gov/. Updated October 4, 2010.
15. Kuo MN, Avery TR, Nguyen CM, et al., editors. Challenges to interhospital comparisons of methicillin-resistant Staphylococcus aureus (MRSA) rates in Orange County, California; Program and abstracts of the Fifth Decennial International Conference on Healthcare-Associated Infections; Atlanta, GA. March 18-22, 2010.
16. Avery TR, Huang SS. Impact of post-discharge events on hospital methicillin-resisitant Staphylococcus aureus (MRSA) rates; Program and abstracts of the Fifth Decennial International Conference on Healthcare-Associated Infections; Atlanta, GA. March 18–22, 2010.
17. Huang SS, Rifas-Shiman SL, Warren DK, et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis. 2007;195:330–338. [PubMed]
18. Robicsek A, Beaumont JL, Peterson LR. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk. Clin Infect Dis. 2009;48:910–913. [PubMed]
19. Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage for methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1994;19(6):1123–1128. [PubMed]
20. Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis. 2001;32(10):1393–1398. [PubMed]
21. Kluytman J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505–520. [PMC free article] [PubMed]
22. Cooper BS, Medley GF, Stone SP, et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci USA. 2004;101(27):10223–10228. [PMC free article] [PubMed]
23. Donker T, Wallinga J, Grundmann H. Patient referral patterns and the spread of hospital-acquired infections through national health care networks. PLoS Comput Biol. 2010;6(3):e1000715. [PMC free article] [PubMed]
24. Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA. 2004;101(10):3709–3714. [PMC free article] [PubMed]
25. Smith DL, Levin SA, Laxminarayan R. Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc Natl Acad Sci USA. 2005;102(8):3153–3158. [PMC free article] [PubMed]
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...